Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2026 28.37%
March 31, 2026 29.03%
December 31, 2025 25.29%
September 30, 2025 28.03%
June 30, 2025 32.21%
March 31, 2025 21.85%
December 31, 2024 29.46%
September 30, 2024 14.95%
June 30, 2024 40.54%
March 31, 2024 31.66%
December 31, 2023 25.58%
September 30, 2023 38.30%
June 30, 2023 19.15%
March 31, 2023 60.29%
December 31, 2022 47.86%
September 30, 2022 25.75%
June 30, 2022 1.78%
March 31, 2022 20.05%
December 31, 2021 96.22%
September 30, 2021 77.34%
June 30, 2021 77.84%
March 31, 2021 90.84%
December 31, 2020 94.81%
September 30, 2020 91.85%
June 30, 2020 91.39%
Date Value
March 31, 2020 88.40%
December 31, 2019 91.33%
September 30, 2019 85.18%
June 30, 2019 91.62%
March 31, 2019 94.24%
December 31, 2018 71.68%
September 30, 2018 87.76%
June 30, 2018 84.85%
March 31, 2018 86.17%
December 31, 2017 86.36%
September 30, 2017 81.23%
June 30, 2017 82.32%
March 31, 2017 73.56%
December 31, 2016 67.37%
September 30, 2016 64.04%
June 30, 2016 57.41%
March 31, 2016 82.32%
December 31, 2015
September 30, 2011 47.29%
June 30, 2011 18.35%
March 31, 2011 80.97%
December 31, 2010 72.05%
September 30, 2010
June 30, 2010 67.86%
March 31, 2010 69.03%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Neuronetics, Inc. 50.09%
Sanara MedTech, Inc. 90.76%
Progyny, Inc. 25.48%
Intelligent Bio Solutions, Inc. 21.68%
TENON Medical, Inc. 63.64%

Gross Profit Margin (Quarterly) Related Metrics